JENNIFER MARTIN: Open Payments
NPI 1922030188 · BEAUFORT, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$437 in 21 payments from 8 companies in 2025. Trend: 2023 $15 · 2024 $253 · 2025 $437
Food & beverage: $437
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 4 | $100 |
| Novo Nordisk Inc | 5 | $95 |
| AstraZeneca Pharmaceuticals LP | 4 | $74 |
| Dexcom, Inc. | 2 | $50 |
| Amgen Inc. | 2 | $48 |
| Abbott Laboratories | 2 | $31 |
| Astellas Pharma US Inc | 1 | $23 |
| Lilly USA, LLC | 1 | $16 |
Products named: Korlym, Wegovy, BREZTRI, Dexcom G6 Transmitter, KRYSTEXXA, Rybelsus, FREESTYLE LIBRE 3, Veozah.
Industry payments across SC — which companies pay providers there.
